Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€2.79

€2.79

16.670%
0.42
16.670%
-
 
20.08.25 / Tradegate WKN: A4BGGM / Name: Biofrontera / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Biofrontera AG Stock

Biofrontera AG dominated the market today, gaining €0.42 (16.670%).

Pros and Cons of Biofrontera AG in the next few years

Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
S********** s********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

News

Biofrontera Q2 Revenue Jumps 15%: https://cdn.content.foolcdn.com/images/1umn9qeh/production/79b766e4527704fb4e4eec7aac870a082e9907fc-1024x1024.png
Biofrontera Q2 Revenue Jumps 15%

Biofrontera(NASDAQ:BFRI) reported fiscal second quarter results for the period ended June 30, 2025, with total revenues rising to $9 million from $7.8 million a year earlier, representing a 15%

Biofrontera Revenue Jumps 15% in Q2
Biofrontera Revenue Jumps 15% in Q2

Biofrontera (NASDAQ:BFRI), a specialty biopharmaceutical company focused on dermatology solutions, released its financial results for the second quarter of fiscal 2025 on August 13, 2025. The